Product correctly added to cart.

discount label
2-Azabicyclo[2.2.2]octane-3-carboxylic acid
View 3D

Biosynth logo

2-Azabicyclo[2.2.2]octane-3-carboxylic acid

CAS: 90103-87-0

Ref. 3D-QDA10387

5mg
208.00 €
50mg
827.00 €
Estimated delivery in United States, on Tuesday 3 Sep 2024

Product Information

Name:
2-Azabicyclo[2.2.2]octane-3-carboxylic acid
Description:

2-Azabicyclo[2.2.2]octane-3-carboxylic acid is a prodrug that is converted to its active form, 2-azabicyclo-[2.2.1]heptane-3-carboxylic acid, in the body by esterases and other enzymes. It is used for the treatment of diabetic retinopathy and arteritis due to its ability to inhibit the activity of protein kinase C (PKC) in endothelial cells. This drug has also been shown to be effective in animal models of migraine and cerebral arteritis, where it reduced the size of blood vessels and prevented blood leakage from them. 2-Azabicyclo[2.2.2]octane-3-carboxylic acid may have beneficial effects on senescence and atrophy in addition to its PKC inhibition properties, which could lead to a reduction in skin wrinkles and age spots as

Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Molecular weight:
155.19 g/mol
Formula:
C8H13NO2
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-QDA10387 2-Azabicyclo[2.2.2]octane-3-carboxylic acid

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".